270 related articles for article (PubMed ID: 19889130)
1. Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium.
Camins A; Verdaguer E; Junyent F; Yeste-Velasco M; Pelegrí C; Vilaplana J; Pallás M
CNS Neurosci Ther; 2009; 15(4):333-44. PubMed ID: 19889130
[TBL] [Abstract][Full Text] [Related]
2. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
Damri O; Shemesh N; Agam G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
Forlenza OV; De-Paula VJ; Diniz BS
ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of SB-415286 on hydrogen peroxide-induced cell death in B65 rat neuroblastoma cells and neurons.
Pizarro JG; Yeste-Velasco M; Rimbau V; Casadesús G; Smith MA; Pallàs M; Folch J; Camins A
Int J Dev Neurosci; 2008; 26(3-4):269-76. PubMed ID: 18342477
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3.
Koh SH; Kim SH; Kwon H; Park Y; Kim KS; Song CW; Kim J; Kim MH; Yu HJ; Henkel JS; Jung HK
Brain Res Mol Brain Res; 2003 Oct; 118(1-2):72-81. PubMed ID: 14559356
[TBL] [Abstract][Full Text] [Related]
6. Lithium and autophagy.
Motoi Y; Shimada K; Ishiguro K; Hattori N
ACS Chem Neurosci; 2014 Jun; 5(6):434-42. PubMed ID: 24738557
[TBL] [Abstract][Full Text] [Related]
7. [Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage].
Pronin AV; Gogoleva IV; Torshin IY; Gromovа OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2):99-108. PubMed ID: 27166488
[TBL] [Abstract][Full Text] [Related]
8. Does lithium prevent Alzheimer's disease?
Forlenza OV; de Paula VJ; Machado-Vieira R; Diniz BS; Gattaz WF
Drugs Aging; 2012 May; 29(5):335-42. PubMed ID: 22500970
[TBL] [Abstract][Full Text] [Related]
9. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
[TBL] [Abstract][Full Text] [Related]
10. Lithium, a potential protective drug in Alzheimer's disease.
Engel T; Goñi-Oliver P; Gómez de Barreda E; Lucas JJ; Hernández F; Avila J
Neurodegener Dis; 2008; 5(3-4):247-9. PubMed ID: 18322403
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
Lai JS; Zhao C; Warsh JJ; Li PP
Eur J Pharmacol; 2006 Jun; 539(1-2):18-26. PubMed ID: 16678157
[TBL] [Abstract][Full Text] [Related]
12. Lithium and Therapeutic Targeting of GSK-3.
Snitow ME; Bhansali RS; Klein PS
Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium.
Aghdam SY; Barger SW
Curr Alzheimer Res; 2007 Feb; 4(1):21-31. PubMed ID: 17316163
[TBL] [Abstract][Full Text] [Related]
14. A new avenue for lithium: intervention in traumatic brain injury.
Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
[TBL] [Abstract][Full Text] [Related]
15. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
[TBL] [Abstract][Full Text] [Related]
16. Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.
Quiroz JA; Machado-Vieira R; Zarate CA; Manji HK
Neuropsychobiology; 2010; 62(1):50-60. PubMed ID: 20453535
[TBL] [Abstract][Full Text] [Related]
17. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
Bauer M; Alda M; Priller J; Young LT;
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
[TBL] [Abstract][Full Text] [Related]
18. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
Marmol F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1761-71. PubMed ID: 18789369
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
Malhi GS; Outhred T
CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
[TBL] [Abstract][Full Text] [Related]
20. Lithium and synaptic plasticity.
Salinas PC; Hall AC
Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
